@article{e55c746d8bd7436abd19fbace201dc2f,
title = "Chronic myeloid leukemia, version 2.2021",
abstract = "Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome (Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t(9;22] that gives rise to a BCR-ABL1 fusion gene. CML occurs in 3 different phases (chronic, accelerated, and blast phase) and is usually diagnosed in the chronic phase. Tyrosine kinase inhibitor therapy is a highly effective first-line treatment option for all patients with newly diagnosed chronic phase CML. This manuscript discusses the recommendations outlined in the NCCN Guidelines for the diagnosis and management of patients with chronic phase CML.",
author = "Deininger, {Michael W.} and Shah, {Neil P.} and Altman, {Jessica K.} and Ellin Berman and Ravi Bhatia and Bhavana Bhatnagar and DeAngelo, {Daniel J.} and Jason Gotlib and Gabriela Hobbs and Lori Maness and Monica Mead and Leland Metheny and Sanjay Mohan and Moore, {Joseph O.} and Kiran Naqvi and Vivian Oehler and Pallera, {Arnel M.} and Mrinal Patnaik and Keith Pratz and Iskra Pusic and Rose, {Michal G.} and Smith, {B. Douglas} and Snyder, {David S.} and Sweet, {Kendra L.} and Moshe Talpaz and James Thompson and Yang, {David T.} and Gregory, {Kristina M.} and Hema Sundar",
note = "Publisher Copyright: {\textcopyright} 2020 Harborside Press. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = oct,
doi = "10.6004/jnccn.2020.0047",
language = "English (US)",
volume = "18",
pages = "1385--1415",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "10",
}